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Computed tomography (CT) is the primary imaging modality used to investigate human 17 
patients with suspected malignant or inflammatory pleural effusion, but there is a lack of 18 
information about the clinical use of this test in dogs. In order to identify CT signs that could 19 
be used to distinguish pleural malignant neoplasia from pleuritis, a retrospective case-20 
control study was done based on dogs that had pleural effusion, pre- and post-contrast 21 
thoracic CT images, and cytological or histopathological diagnosis of malignant or 22 
inflammatory pleural effusion. There were 20 dogs with malignant pleural effusion (13 23 
mesothelioma, 6 carcinoma; 1 lymphoma), and 32 dogs with pleuritis (18 pyothorax; 14 24 
chylothorax). Compared to dogs with pleuritis, dogs with malignant pleural effusions were 25 
significantly older (median 8.5 years versus 4.9 years, p=0.001), more frequently had CT 26 
signs of pleural thickening (65% versus 34%, p= 0.05), tended to have thickening of the 27 
parietal pleura only (45% versus 3%, p=0.002) and had more marked pleural thickening 28 
(median 3mm versus 0mm, p=0.03). CT signs of thoracic wall invasion were observed only in 29 
dogs with malignant pleural effusions (p= 0.05). There were no significant differences in 30 
pleural fluid volume, distribution or attenuation, degree of pleural contrast accumulation, 31 
amount of pannus, or prevalence of mediastinal adenopathy. Although there was 32 
considerable overlap in findings in dogs with malignant pleural effusion and pleuritis, 33 
marked thickening affecting the parietal pleural alone and signs of thoracic wall invasion on 34 
CT support diagnosis of pleural malignant neoplasia, and may help prioritize further 35 
diagnostic testing.   36 
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Introduction  37 
Pleural fluid accumulation may occur as a result of several different pathologic mechanisms 38 
that determine the nature of the fluid.1 Inspection of pleural fluid is the basis for tentative 39 
diagnosis in many instances2; however, pleural fluid containing blood, moderate protein and 40 
non-specific cellular content can occur with neoplasia, inflammatory or idiopathic 41 
conditions3,4, and fluid analysis alone may be insufficient for diagnosis. Although low in 42 
prevalence, the neoplasms that most frequently cause pleural effusion in dogs by direct 43 
seeding and invasion of the pleura are mesothelioma and carcinoma. Mesothelioma, a 44 
primary malignant neoplasm of the pleura5-7, pericardium8-10 or peritoneum10-12, can be 45 
particularly difficult to diagnose on routine cytologic preparations because malignant 46 
mesothelial cells may appear similar to the reactive mesothelial cells seen with 47 
inflammatory pleural conditions.1,6,13,14  Carcinoma metastasis to the pleura can also be 48 
difficult to diagnose cytologically and may require immunocytochemical analysis of the 49 
effusion or histopathology.15  Metastasis to the pleura could occur with any type of 50 
carcinoma, but in the dog this condition is mainly associated with primary epithelial lung 51 
tumors, mammary carcinoma, prostatic carcinoma and transitional cell carcinoma of the 52 
urinary bladder.16  Dogs with pleural carcinoma (or sarcoma) usually have a primary tumor 53 
elsewhere, the detection of which aids diagnosis of the pleural effusion. 54 
Diagnostic imaging is indicated for patients with pleural effusion of unknown cause. 55 
Depending on clinical signs, ultrasonography and/or radiography may be performed first 56 
and may enable detection of various well-recognized predisposing causes of pleural 57 
effusion, such as thoracic masses, lung lobe torsion, pericardial disease, and cardiac failure. 58 
When echocardiography and radiography are negative or findings are non-specific, 59 
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computed tomography (CT) is indicated to examine the thorax in more detail.17 CT is the 60 
primary imaging modality used for humans with suspected pleural neoplasia.18-21 There have 61 
been numerous studies of the CT features of pleural mesothelioma and other pleural 62 
malignancies in humans.18-24 CT features that support a diagnosis of pleural malignant 63 
neoplasia rather than pleuritis include pleural thickening >1cm, nodular thickening, 64 
interlobar distribution of thickening, and thoracic volume contraction.18-26 65 
There have been fewer reports of imaging findings in dogs with malignant neoplasia 66 
affecting primarily the pleura. The radiographic signs primarily represent pleural or 67 
pericardial fluid accumulation, although pleural masses due to mesothelioma may be visible 68 
in radiographs made after fluid drainage.6 Few reports describe use of CT to examine the 69 
pleura in dogs. Multifocal, irregular thickening of the parietal pleura on CT was illustrated in 70 
a report of a dog with pleural mesothelioma.27 Pleural thickening in CT images was also 71 
reported in 8/12 (67%) dogs28 and 3/10 (30%) dogs29 with pyothorax, but was not described 72 
in detail. A more recent study30 described the CT findings in 7 dogs with various pleural 73 
conditions including primary and metastatic neoplasia and pleuritis. Masses and nodular 74 
lesions affecting the pleura were observed in 5/7 (71%) dogs, but there was no apparent 75 
association between the morphologic features of pleural lesions and the specific diagnosis.30 76 
Even on gross inspection, pleural masses due to mesothelioma may resemble granulation 77 
tissue.10 For patients in which pleural masses are suspected but not visualized clearly or 78 
imaging findings are non-specific, thoracoscopy or thoracotomy for pleural biopsy is 79 
indicated.  80 
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The aim of the present study was to compare the results of CT in a larger series of dogs with 81 
pleural effusion secondary to pleural malignant neoplasia or pleuritis in order to identify 82 
signs that could be used to distinguish these conditions.  83 
 84 
Materials and Methods  85 
Ethical approval was granted by the Clinical Research Ethical Review Board at the Royal 86 
Veterinary College. For this retrospective case-control study, medical records from the 87 
Queen Mother Hospital for Animals (QMHA) in the period 2010-2016 were searched by one 88 
observer (TCW) for dogs that had pleural effusion, pre- and post-contrast thoracic CT 89 
images, and cytologic or histopathologic diagnosis of pleural effusion secondary to pleural 90 
malignant neoplasia or pleuritis. For the purposes of this study, pleuritis included pyothorax 91 
and chylothorax. Although chylothorax has various primary causes, the effect of chyle on 92 
the pleura is inflammatory.31 Dogs with primary neoplasia affecting non-pleural thoracic 93 
structures were not included. Dogs in which a migrating thoracic foreign body was visible in 94 
CT images were also not included.   95 
Diagnosis of malignant pleural neoplasia was based on compatible cytologic, histologic 96 
and/or immunohistochemical findings. Criteria for pleural malignant neoplasia were 97 
characteristic cellular morphology on cytologic16 or histologic preparations and, when 98 
diagnosis was uncertain, immunocytochemistry or immunohistochemistry for vimentin and 99 
cytokeratin.15 Diagnosis of pyothorax was based on cytologic evidence of suppurative 100 
bacterial infection of pleural fluid with or without positive culture. Diagnosis of chylothorax 101 
was based on finding small lymphocytes to be the most numerous cell type and elevated 102 
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pleural fluid triglyceride concentration (>2.84mmol/L). In all instances, diagnosis by a board-103 
certified veterinary clinical pathologist was required for inclusion in the study.  104 
As part of the inclusion criteria, all CT images were acquired using the same multi-slice 105 
scanner (MX8000 IDT, Phillips Best, the Netherlands), and transverse images were reviewed 106 
using a DICOM viewer (OsiriX version 7.01). Studies lacking pre- and post-contrast series 107 
obtained with optimal settings for soft tissue examination were excluded. For the purposes 108 
of this study, optimal settings were helical acquisition, slice thickness up to 3mm, medium 109 
frequency (‘soft tissue’) reconstruction algorithm, and with post-contrast CT images 110 
acquired 60 seconds after the start of intravenous injection of 2ml/kg of iohexol 300mg/ml 111 
(Omnipaque 300, GE Healthcare, Oslo, Norway). Studies with evidence of excessive motion 112 
blur were also excluded. 113 
 All CT studies were reviewed by a single board-certified radiologist (CRL) without 114 
knowledge of signalment, clinical history or diagnosis. In cases where multiple CT studies 115 
had been done, only the first CT study with evidence of pleural effusion was selected for 116 
review. CT images were reviewed using soft tissue (width 320 HU; level 80 HU) and lung 117 
(width 1500 HU; level -500 HU) windows with reference to several subjective and objective 118 
criteria. The presence of pericardial, pleural or mediastinal fluid, the distribution of pleural 119 
fluid (symmetrical or asymmetrical), presence of pleural thickening, presence of pannus, 120 
mediastinal lymphadenopathy, and evidence of thoracic wall invasion were recorded. 121 
Pleural fluid average attenuation measurements (Hounsfield units, HU) were made using a 122 
single circular region of interest placed on the largest visible collection of pleural fluid in pre-123 
contrast images. Pleural thickening was defined as a hyperdense line at the border of 124 
pleural fluid collections in post-contrast CT images, and was classified by site (visceral, 125 
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parietal or both) and morphology (diffuse, lobar, nodular, mass-like and/or calcified). 126 
Attenuation measurements using a point region of interest and a thickness measurement 127 
(mm) were recorded at the site of maximal pleural thickening where applicable. The term 128 
pannus refers to fibrovascular tissue within the pleural cavity that tends to form sheets and 129 
exhibits enhancement following intravenous contrast administration. Subjective assessment 130 
of pleural fluid volume, amount of pannus, and degree of mediastinal lymphadenopathy 131 
were recorded using an ordinal scale (0, none; 1, slight; 2, marked). Diagnosis of thoracic 132 
wall invasion was based on observing thickening of intercostal muscles, loss of 133 
intermuscular fat planes, streaking of intercostal or sub-cutaneous fat, periosteal reaction 134 
on ribs or sternebrae and/or lysis of ribs or sternebrae.  135 
Data were analyzed using a commercial statistical software package (SPSS 22, IBM). Fisher’s 136 
exact test was used to test differences in categorical data, and Mann-Whitney tests were 137 
utilized to test differences in continuous data between dogs that had pleural malignant 138 
neoplasia or pleuritis. Differences with p<0.05 were considered significant. Binomial 95% 139 
confidence intervals (CI) for estimates of likelihood ratios were determined using the 140 
statistical calculator provided by the Centre for Evidence Based Medicine 141 
(http://ktclearinghouse.ca/cebm/practise/ca/calculators/statscalc).  142 
 143 
Results  144 
Fifty-two dogs satisfied all criteria for inclusion in the study. There were 24 females (14 145 
neutered) and 28 males (18 neutered) representing 22 different pedigree dog breeds plus 6 146 
crossbred dogs. Twenty dogs had pleural malignant neoplasia (13 mesothelioma, 6 147 
metastatic carcinoma, 1 lymphoma) and 32 had pleuritis (18 pyothorax, 14 chylothorax). 148 
8 
 
Diagnosis of mesothelioma was based on histology in 8 dogs, immunohistochemistry in one, 149 
immunocytochemistry in one and cytology in 3 dogs. Diagnosis of carcinoma or lymphoma 150 
was based on cytology in each instance. Median age of dogs that had pleural malignant 151 
neoplasia was 8.5 years (range 4.0-12.8 years) compared to 4.9 years (range 1.3-13.0 years) 152 
for dogs with pleuritis (p=0.001).  153 
Results of CT are summarized in Table 1.  Pleural thickening was the sign most frequently 154 
observed in dogs with malignant pleural effusion (figure 1) whereas enlarged mediastinal 155 
lymph nodes was the sign most frequently observed in dogs with pleuritis. Dogs with 156 
malignant pleural effusion more frequently had CT signs of pleural thickening (65% versus 157 
34%, p= 0.03), tended to have thickening of the parietal pleura only (65% versus 13%, 158 
p=0.01) and had more marked pleural thickening (median 3mm versus 0mm, p=0.01). CT 159 
signs of thoracic wall invasion were observed only in dogs with malignant pleural effusions 160 
(p=0.05) (figure 2). Likelihood ratios for pleural malignant neoplasia for categorical CT signs 161 
of significance or borderline significance were: pleural thickening 1.9 (95% CI 1.1-3.0); 162 
parietal pleural thickening only 5.2 (95% CI 2.0-13.7); and thoracic wall invasion 11.0 (95% CI 163 
0.6-202.4). The likelihood ratio for visceral pleural thickening as a signs of pleuritis was 3.1 164 
(95% CI 0.8-12.8). The criterion pleural thickening >1cm was not significantly associated with 165 
pleural malignant neoplasia. There were also no significant differences in pleural fluid 166 
volume, distribution or attenuation, degree of pleural contrast accumulation, amount of 167 
pannus (figure 3) or prevalence of mediastinal adenopathy or pulmonary nodules. Cause of 168 
pulmonary nodules in dogs with pleuritis was not determined: none had signs of malignant 169 




Discussion  172 
In this study there was marked overlap in the CT signs observed in dogs with malignant 173 
pleural effusion and dogs with pleuritis. As reported in humans18-26, pleural thickening may 174 
be observed in patients with either malignant effusion or pleuritis, hence although CT is 175 
indicated as an aid to differential diagnosis of pleural effusion, it appears to be inaccurate. 176 
In the dogs in the present series, the most discriminating CT sign (i.e. that with the highest 177 
likelihood ratio for pleural malignancy) was thoracic wall invasion; however, this was 178 
observed in only 15% dogs with mesothelioma, which suggests it is not a sensitive sign, and 179 
was of borderline statistical significance because of the wide confidence interval associated 180 
with small number of affected dogs. Parietal pleural thickening in the absence of visceral 181 
pleural thickening also appears to be a useful discriminating sign. This was observed in 45% 182 
dogs with malignant pleural effusion and only 3% dogs with pleuritis. Conversely, visceral 183 
pleural thickening was observed in 10% dogs with malignant pleural effusion and 31% dogs 184 
with pleuritis, although this difference was not significant. Malignant pleural effusion was 185 
associated with a greater median pleural thickening that pleuritis, but there were no 186 
significant differences in the prevalence of nodular thickening or calcified pleural lesions. 187 
Foci of calcification or ossification in mesotheliomas has been reported infrequently in 188 
dogs8, hence the potential diagnostic value of this sign appears to be limited.  189 
The normal pleura of humans is too thin to be visible in CT images.20  On the basis of 190 
unpublished observations in a limited number of dogs with pleural transudates, we believe 191 
the same is true in dogs; therefore, observing a hyperdense line in post-contrast CT images 192 
at the border of a pleural fluid collection was considered to be evidence of pleural 193 
thickening even if the line was too thin for accurate measurement of thickness or 194 
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attenuation value. Visceral pleural thickening is most clearly visible in animals that also have 195 
pneumothorax (usually because of pleural drain placement).  196 
The mechanisms that promote pleural effusion are similar in animals with neoplastic and 197 
inflammatory pleural conditions, including increased permeability of the pleural 198 
microvasculature and impaired lymphatic drainage from the pleural cavity because of tumor 199 
or fibrosis obstructing lymphatic vessels.1,20 The presence of a thoracostomy tube can also 200 
induce pleural effusion, with potential for secondary infection when tubes have been in 201 
placed more than a few days.32  202 
Markedly asymmetrical (including unilateral) distribution of pleural fluid was observed in 203 
the present study only in dogs with pleuritis, and has been noted in an earlier study of dogs 204 
with pyothorax.28  This finding could reflect restricted flow of pleural fluid by increased 205 
viscosity and/or obstruction of normal routes by fibrin ‘peel’ that coats the pleura. 206 
Organization of fibrin peel with ingrowth of capillaries and fibroblasts occurs within 7 days 207 
of the onset of pleuritis.20 Pannus is a term used for fibrovascular tissue that occurs in 208 
inflammatory conditions that tends to form sheets over structures, such as the cornea.33 209 
This term is also applicable to the sheet- or mass-like tissue that replaces fibrin peel in dogs 210 
with inflammatory or reactive pleural effusion.34  In CT images, pannus may be distinguished 211 
from fibrin peel because it enhances after intravenous contrast administration, and 212 
distinguished from true pleural thickening when it occupies the pleural cavity with minimal 213 
contact with the pleural surfaces; however, without detailed imaging-pathologic correlation, 214 
it is possible that some masses due to pleural neoplasia in this series could have been 215 
misinterpreted as pannus, and vice versa, particularly when pannus is thick and/or in broad 216 
contact with the pleura. Compared to CT, ultrasonography may be advantageous in 217 
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distinguishing these entities because real-time imaging displaying motion of sheet-like tissue 218 
would support diagnosis of pannus; however, sessile, immobile pleural masses may remain 219 
difficult to diagnose on the basis of their imaging features alone.  220 
Diagnosis of malignant pleural effusion is most challenging in patients in which no primary 221 
neoplasm can be found elsewhere in the body. Whereas most dogs with pleural carcinoma 222 
will have a primary neoplasm in the lung or abdomen, no other primary neoplasm will be 223 
found in dogs with mesothelioma, hence mesothelioma is the more challenging diagnosis. In 224 
the present study, only 3 dogs with mesothelioma were diagnosed on the basis of cytology 225 
alone; most required immunological testing or histology. When mesothelioma is suspected 226 
there is a need for detailed examination of the pleura. The importance of the present study 227 
is that it provides new information about use of CT to examine the pleura, which should 228 
help address this clinical problem.  229 
To minimize bias, and to replicate the indication for detailed imaging examination of the 230 
pleura, we did not include dogs in this study whose CT images contained signs that strongly 231 
suggested either neoplasia or inflammatory conditions, such as intrathoracic masses or 232 
foreign material. Presence of a pulmonary mass, for example, could bias an observer 233 
towards an assumption of malignant pleural effusion, and to overemphasize related findings 234 
such as adenopathy or pleural thickening. The occurrence of pulmonary nodules in a similar 235 
proportion of dogs with malignant effusion and dogs with pleuritis emphasizes the non-236 
specific nature of that finding.  237 
The main limitation of the present study is the small number of dogs included. This mainly 238 
reflects the difficulty collecting larger numbers of dogs with primary pleural neoplasia, but is 239 
problematic because it means that our estimates of the prevalence of various CT features 240 
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will be imprecise, which limits the statistical power of the tests done to compare the 241 
neoplastic and pleuritis groups.  242 
Neoplastic processes resulting in pleural effusion can present a significant diagnostic 243 
challenge and have been associated historically with a poor prognosis.6,7,13  Recent advances 244 
in malignant effusion management with pleural ports and intracavitary chemotherapy 245 
appear to provide an improved prognosis.35,36  Definite diagnosis of mesothelioma 246 
sometimes requires pleural biopsy via thoracoscopy or thoracotomy. Invasive procedures 247 
such as these may not be favored by veterinarians or owners in the absence of supportive 248 
imaging findings. On the basis of the present study, it may be concluded that CT signs of 249 
marked thickening affecting the parietal pleural alone and signs of thoracic wall invasion 250 
support diagnosis of pleural malignant neoplasia whereas visceral pleural thickening 251 
supports a diagnosis of pleuritis. These results may help prioritize further diagnostic testing 252 
of dogs with pleural effusion.   253 
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Table 1. Computed tomographic features of malignant and inflammatory pleural effusions in 355 
52 dogs 356 
 357 
 Malignant Inflammatory p-value 358 
Computed tomographic feature (n=20) (n=32) 359 
 360 
Pleural fluid median (range) attenuation (HU) 19 (12-32) 20 (7-45) NS 361 
Asymmetrical distribution of fluid 0 5 (16%) NS 362 
Pleural thickening 17 (85%) 14 (44%) 0.03 363 
Parietal/visceral/both 13/1/1 4/6/4 0.01 364 
Diffuse 6 (30%) 7 (22%) NS 365 
Nodular 6 (30%) 7 (22%) NS 366 
Median maximal thickness (mm) 3 (0-40) 0 (0-38) 0.01 367 
Pleura >1cm thick 6 (30%) 4 (13%) NS 368 
Median pre-/post-C (HU) 38/98 38/77 NS 369 
Median difference 61 (12-98) 35 (10-66) NS 370 
Calcification of pleura 2 (10%) 0 NS 371 
Pannus 5 (25%) 10 (31%) NS 372 
Thoracic wall invasion 3 (15%) 0 0.05 373 
Pericardial fluid 1 (5%) 1 (3%) NS 374 
Mediastinal fluid 2 (10%) 3 (6%) NS 375 
Mediastinal adenopathy 11 (55%) 21 (66%) NS 376 
Pulmonary nodules  5 (25%) 4 (13%) NS 377 
____________________ 378 




Figure 1. Examples of diffuse pleural thickening. A) Slight diffuse thickening of the parietal 381 
pleura (arrowheads) in a dog with mesothelioma; B) Nodular thickening of the parietal 382 
pleura (arrowheads) in a dog with mesothelioma; C)  Marked irregular thickening of the 383 
parietal and mediastinal pleura (arrowheads) in a dog with pyothorax; D) Slight diffuse 384 
thickening of the visceral pleura (arrowheads) in a dog with pyothorax.  A-C soft tissue 385 




Figure 2. Examples of thoracic wall invasion by mesothelioma. A) Broad mass (*) involving 388 
parietal pleura and adjacent intercostal muscles; B) Locally invasive mass (large arrowheads) 389 
thickening the inner layer of thoracic wall (small arrowheads) and obliterating the fat plane 390 
between muscles of the thoracic wall. Both images displayed using a soft tissue window 391 
(width 320 HU; level 80 HU).  392 
 393 
 394 
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Figure 3. Examples of pannus (A and B) in dogs with pyothorax. In each instance, the 396 
morphology of pannus is a thick, folded sheet of tissue (arrowheads) that appears separate 397 
from the pleura. An enlarged sternal lymph node (*) is visible in B. Both images displayed 398 
using a soft tissue window (width 320 HU; level 80 HU).  399 
 400 
